$PALI
PALISADE BIO, INC.

2020 Q1 Form 10-K Financial Statement

#000117184320002061 Filed on March 27, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 2018 Q4
Revenue $6.020K $15.39K $0.00
YoY Change 140.8% -94.08% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.300M $4.590M $930.0K
YoY Change 38.3% 0.66% -28.46%
% of Gross Profit
Research & Development $696.9K $4.061M $880.0K
YoY Change -53.98% 2.56% -28.46%
% of Gross Profit
Depreciation & Amortization $30.00K $49.00K $30.00K
YoY Change -25.0% -41.67% -50.0%
% of Gross Profit
Operating Expenses $1.996M $8.647M $1.810M
YoY Change -18.81% 1.5% -28.17%
Operating Profit -$1.990M -$8.632M
YoY Change -18.97% 4.51%
Interest Expense $2.579K $8.920K $1.480M
YoY Change 27.86% 15.87% -240.95%
% of Operating Profit
Other Income/Expense, Net -$5.585M $280.0K $0.00
YoY Change 749.49% -91.6% -100.0%
Pretax Income -$7.580M -$8.350M -$320.0K
YoY Change 143.73% 69.72% -90.36%
Income Tax
% Of Pretax Income
Net Earnings -$2.384M -$8.352M -$320.0K
YoY Change -23.44% 69.59% -90.36%
Net Earnings / Revenue -39601.33% -54252.64%
Basic Earnings Per Share
Diluted Earnings Per Share -$5.574M -$22.57M -$2.462M
COMMON SHARES
Basic Shares Outstanding 9.428M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.03M $5.110M $5.790M
YoY Change 150.12% -11.74% -50.39%
Cash & Equivalents $10.03M $5.110M $5.787M
Short-Term Investments $0.00
Other Short-Term Assets $410.0K $510.0K $360.0K
YoY Change 36.67% 41.67% -10.0%
Inventory
Prepaid Expenses $414.7K $363.3K
Receivables $19.01K $20.00K $294.1K
Other Receivables $0.00 $0.00 $70.00K
Total Short-Term Assets $10.46M $5.650M $6.508M
YoY Change 130.57% -13.21% -47.72%
LONG-TERM ASSETS
Property, Plant & Equipment $31.13K $40.00K $90.31K
YoY Change -58.86% -55.56% -47.76%
Goodwill
YoY Change
Intangibles $649.7K $763.5K
YoY Change -12.01% -13.57%
Long-Term Investments
YoY Change
Other Assets $30.00K $230.0K $23.97K
YoY Change -43.77% 1050.0% 73.0%
Total Long-Term Assets $896.8K $930.0K $1.176M
YoY Change 3.39% -20.51% -18.08%
TOTAL ASSETS
Total Short-Term Assets $10.46M $5.650M $6.508M
Total Long-Term Assets $896.8K $930.0K $1.176M
Total Assets $11.36M $6.580M $7.684M
YoY Change 110.16% -14.32% -44.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $960.0K $820.0K $830.0K
YoY Change -11.11% -1.2% -5.68%
Accrued Expenses $130.0K $140.0K $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.186M $1.220M $1.051M
YoY Change -1.97% 16.19% -30.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $230.0K $580.0K
YoY Change -78.26% -60.34% -84.94%
Total Long-Term Liabilities $200.0K $230.0K $580.0K
YoY Change -78.26% -60.34% -84.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.186M $1.220M $1.051M
Total Long-Term Liabilities $200.0K $230.0K $580.0K
Total Liabilities $1.383M $1.460M $1.635M
YoY Change -35.21% -10.43% -69.55%
SHAREHOLDERS EQUITY
Retained Earnings -$229.6M -$213.6M
YoY Change 5.91% 2.36%
Common Stock $94.28K $9.103K
YoY Change -48.21% -94.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.23M $5.130M $6.050M
YoY Change
Total Liabilities & Shareholders Equity $11.36M $6.580M $7.684M
YoY Change 110.16% -14.32% -44.65%

Cashflow Statement

Concept 2020 Q1 2019 2018 Q4
OPERATING ACTIVITIES
Net Income -$2.384M -$8.352M -$320.0K
YoY Change -23.44% 69.59% -90.36%
Depreciation, Depletion And Amortization $30.00K $49.00K $30.00K
YoY Change -25.0% -41.67% -50.0%
Cash From Operating Activities -$1.678M -$7.256M -$1.660M
YoY Change 0.7% -5.68% -27.51%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.593M 6.590M 1.710M
YoY Change -5734.49% 263.21% -1810.0%
NET CHANGE
Cash From Operating Activities -1.678M -7.256M -1.660M
Cash From Investing Activities 0.000
Cash From Financing Activities 6.593M 6.590M 1.710M
Net Change In Cash 4.915M -672.2K 50.00K
YoY Change -375.68% -23.61% -102.09%
FREE CASH FLOW
Cash From Operating Activities -$1.678M -$7.256M -$1.660M
Capital Expenditures $0.00
Free Cash Flow -$7.256M -$1.660M
YoY Change -5.7% -27.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2018 snca Effective Income Tax Rate Reconciliation Change In Fair Value Of Liability Classified Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfLiabilityClassifiedWarrantsPercent
-0.173
CY2019 snca Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
236
CY2019 snca Writeoff Of Related Party Receivable And Other Income Expense
WriteoffOfRelatedPartyReceivableAndOtherIncomeExpense
277906
CY2018 snca Writeoff Of Related Party Receivable And Other Income Expense
WriteoffOfRelatedPartyReceivableAndOtherIncomeExpense
5391
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21064
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
294057
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
135686
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001357459
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9428011
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
4578167
CY2019 dei Entity Registrant Name
EntityRegistrantName
Seneca Biopharma, Inc.
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2019 dei Trading Symbol
TradingSymbol
snca
CY2019Q4 snca Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
824406
CY2018Q4 snca Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
832564
CY2019Q1 snca Additional Research And Development Expense Due To Modifications
AdditionalResearchAndDevelopmentExpenseDueToModifications
102000
CY2019 snca Cost Reimbursements From Sbir Grant As Offset To Research And Development Expenses
CostReimbursementsFromSBIRGrantAsOffsetToResearchAndDevelopmentExpenses
459000
CY2018 snca Cost Reimbursements From Sbir Grant As Offset To Research And Development Expenses
CostReimbursementsFromSBIRGrantAsOffsetToResearchAndDevelopmentExpenses
538000
CY2019 snca Effective Income Tax Rate Reconciliation Change In Fair Value Of Liability Classified Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfLiabilityClassifiedWarrantsPercent
-0.016
CY2019 snca Increase Decrease In Lease And Other Noncurrent Liabilities
IncreaseDecreaseInLeaseAndOtherNoncurrentLiabilities
-34572
CY2018 snca Increase Decrease In Lease And Other Noncurrent Liabilities
IncreaseDecreaseInLeaseAndOtherNoncurrentLiabilities
-1876
CY2019 snca Increase Decrease In Rou And Other Assets
IncreaseDecreaseInROUAndOtherAssets
-39643
CY2018 snca Increase Decrease In Rou And Other Assets
IncreaseDecreaseInROUAndOtherAssets
3991
CY2019Q4 snca Operating Lease Rightofuse Asset And Other Assets Noncurrent
OperatingLeaseRightofuseAssetAndOtherAssetsNoncurrent
227036
CY2018Q4 snca Operating Lease Rightofuse Asset And Other Assets Noncurrent
OperatingLeaseRightofuseAssetAndOtherAssetsNoncurrent
23965
CY2019 snca Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
6552842
CY2018 snca Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
1828000
CY2019Q4 snca Shortterm Debt And Other Liabilities Current
ShorttermDebtAndOtherLiabilitiesCurrent
264665
CY2018Q4 snca Shortterm Debt And Other Liabilities Current
ShorttermDebtAndOtherLiabilitiesCurrent
218602
CY2018 snca Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
1828000
CY2019 snca Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
6552842
CY2019 snca Stock Issued During Period Value Rsu And Option Exercises Net Of Forfeitures
StockIssuedDuringPeriodValueRSUAndOptionExercisesNetOfForfeitures
CY2019 snca Stock Issued During Period Value Rounding Adjustment Related To Reverse Stock Split
StockIssuedDuringPeriodValueRoundingAdjustmentRelatedToReverseStockSplit
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
950417
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
902260
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6186
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-413
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
227067058
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219654753
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
634082
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
880789
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
880789
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
634082
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
95000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
102000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7300000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q4 us-gaap Assets
Assets
6583889
CY2018Q4 us-gaap Assets
Assets
7684450
CY2019Q4 us-gaap Assets Current
AssetsCurrent
5646881
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6508393
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5787110
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6674940
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5114917
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-672193
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-887830
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3866457
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
910253
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3866457
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
910253
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
38665
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9103
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8357424
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4927661
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-545792
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7726
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
455994
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2741660
CY2019 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-455994
CY2018 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
2741660
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1001786
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2749386
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46685253
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46229259
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
43190604
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42580533
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
889372
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1005255
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2605277
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2643471
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46685253
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46229259
CY2019 us-gaap Depreciation
Depreciation
49000
CY2018 us-gaap Depreciation
Depreciation
84000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
143859
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
185803
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
499138
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3269148
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
84596
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
583734
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
63938
CY2019Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
CY2018Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
298238
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.80
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.54
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-6018
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7930
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.055
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
204300
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.557
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.064
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.663
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.288
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.539
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.053
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.05
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P219D
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
155000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1337507
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1242900
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
75000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
75000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
75000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
75000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
75000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2006443
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2006443
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
668936
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
763543
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18342
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4585638
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4559265
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15741
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36991
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-272993
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18745
CY2019 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
CY2018 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-62064
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
135686
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-418625
CY2019 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-47414
CY2018 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
11490
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
142310
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-32303
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
668936
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
763543
CY2019 us-gaap Interest Expense
InterestExpense
8920
CY2018 us-gaap Interest Expense
InterestExpense
7698
CY2019 us-gaap Interest Paid Net
InterestPaidNet
8920
CY2018 us-gaap Interest Paid Net
InterestPaidNet
7698
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
67731
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
78780
CY2019 us-gaap Lease Cost
LeaseCost
108100
CY2019Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.1275
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
235909
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
53503
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
13650
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
58027
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
56190
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
54539
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
54997
CY2019Q4 us-gaap Liabilities
Liabilities
1457896
CY2018Q4 us-gaap Liabilities
Liabilities
1634900
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6583889
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7684450
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1224757
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1051166
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6589505
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1814233
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4998286
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7255680
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7692419
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-4924617
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-8351651
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
280043
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3334839
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Operating Expenses
OperatingExpenses
8647088
CY2018 us-gaap Operating Expenses
OperatingExpenses
8519456
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-8631694
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-8259456
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
171000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
194200
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
164000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
148543
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
160000000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
362176
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3044
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5773
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5773
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3044
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1714
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200000
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
2000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
510900
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
363288
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
5000000
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
414320
CY2018 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
349578
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
236
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
991453
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
992571
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41036
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
90311
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
880789
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
634082
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7441532
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
207813
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
78.30
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
38197
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
228183
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.45
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.40
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
81674
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
271660
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
67.90
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
61.83
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
215.60
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.78
CY2019 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
377893
CY2018 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
363345
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4061450
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3960191
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-221975544
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213623893
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15394
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
260000
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
271660
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y146D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y292D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y36D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
671100
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
205000
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8515129
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6049550
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5125993
CY2019 us-gaap Sublease Income
SubleaseIncome
86100
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The consolidated financial statements include significant estimates for the expected economic life and value of our licensed technology and related patents, our net operating loss and related valuation allowance for tax purposes, the fair value of our liability classified warrants and our share-based compensation related to employees and directors, consultants and advisors, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div></div></div></div></div></div></div></div></div>
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
23200
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2197434
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
653221

Files In Submission

Name View Source Status
0001171843-20-002061-index-headers.html Edgar Link pending
0001171843-20-002061-index.html Edgar Link pending
0001171843-20-002061.txt Edgar Link pending
0001171843-20-002061-xbrl.zip Edgar Link pending
clinical_programs.jpg Edgar Link pending
exh_1025.htm Edgar Link pending
exh_1402.htm Edgar Link pending
exh_2301.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_431.htm Edgar Link pending
f10k_032720p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snca-20191231.xml Edgar Link completed
snca-20191231.xsd Edgar Link pending
snca-20191231_cal.xml Edgar Link unprocessable
snca-20191231_def.xml Edgar Link unprocessable
snca-20191231_lab.xml Edgar Link unprocessable
snca-20191231_pre.xml Edgar Link unprocessable